Vanguard Group Inc Pyxis Oncology, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,149,396 shares of PYXS stock, worth $2.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,149,396

Previous 2,436,728 11.79%

Holding current value

$2.28 Million

Previous $2.39 Million 0.96%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$0.88 - $1.35 $252,852 - $387,898	-287,332 Reduced 11.79%	2,149,396 $2.36 Million
Q1 2025 May 09, 2025	SELL	$0.98 - $1.76 $4,336 - $7,788	-4,425 Reduced 0.18%	2,436,728 $2.39 Million
Q4 2024 Feb 11, 2025	BUY	$1.54 - $4.77 $12,628 - $39,114	8,200 Added 0.34%	2,441,153 $3.78 Million
Q3 2024 Nov 13, 2024	BUY	$2.83 - $3.94 $1.05 Million - $1.47 Million	372,509 Added 18.08%	2,432,953 $8.93 Million
Q2 2024 Aug 13, 2024	BUY	$3.06 - $5.58 $2.02 Million - $3.68 Million	659,019 Added 47.02%	2,060,444 $6.82 Million
Q1 2024 May 10, 2024	BUY	$2.03 - $6.59 $192,322 - $624,336	94,740 Added 7.25%	1,401,425 $5.97 Million
Q4 2023 Feb 14, 2024	BUY	$1.4 - $2.09 $233,018 - $347,863	166,442 Added 14.6%	1,306,685 $2.35 Million
Q3 2023 Nov 14, 2023	BUY	$1.6 - $2.78 $70,070 - $121,747	43,794 Added 3.99%	1,140,243 $2.27 Million
Q2 2023 Aug 14, 2023	BUY	$2.46 - $4.07 $83,394 - $137,973	33,900 Added 3.19%	1,096,449 $2.81 Million
Q1 2023 May 15, 2023	BUY	$1.38 - $6.0 $199,716 - $868,332	144,722 Added 15.77%	1,062,549 $4.26 Million
Q4 2022 Feb 10, 2023	BUY	$1.14 - $2.0 $505 - $886	443 Added 0.05%	917,827 $1.23 Million
Q3 2022 Nov 14, 2022	BUY	$1.88 - $3.03 $128,411 - $206,961	68,304 Added 8.04%	917,384 $1.81 Million
Q2 2022 Aug 12, 2022	BUY	$2.02 - $4.53 $651,997 - $1.46 Million	322,771 Added 61.33%	849,080 $2.02 Million
Q1 2022 May 13, 2022	BUY	$4.04 - $11.43 $24,284 - $68,705	6,011 Added 1.16%	526,309 $2.13 Million
Q4 2021 Feb 14, 2022	BUY	$8.39 - $13.64 $4.37 Million - $7.1 Million	520,298 New	520,298 $5.71 Million

Others Institutions Holding PYXS

# of Institutions

Shares Held

22.5M

Call Options Held

138K

Put Options Held

30.9K

View Full List

About Pyxis Oncology, Inc.

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $37.2M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

More about PYXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Pyxis Oncology, Inc. Transaction History